The 691 Patent was previously the subject of invalidity allegations by Cobalt and Apotex in separate applications brought under the pre-amended Regulations. In each decision, the Federal Court found ...

The Food and Drug Administration has approved Amneal’s bimatoprost ophthalmic solution 0.01% (2.5 ml, 5 ml and 7.5 ml), which is the generic of Allergan’s Lumigan. Bimatoprost ophthalmic solution 0.01 ...

A federal judge has ruled that Irvine-based Allergan Inc.’s patent on its Lumigan glaucoma drug is valid and was infringed upon by two generic versions. U.S. District Court Judge Sue Robison ruled ...

NEW YORK (Reuters) - An Akorn Inc unit's proposed generic glaucoma drug infringed three Allergan Inc patents on its Lumigan topical treatment for the eye disease, a U.S. appeals court ruled on Tuesday ...

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that new nonclinical data on NCX 470 (0.1%) demonstrating greater intraocular pressure ...

Irvine drug maker Allergan Inc. said Friday that regulators cleared Lumigan, its prescription eye drop, as a treatment for an eye condition that’s associated with glaucoma or ocular hypertension. The ...